India Tightens Pregabalin Regulations Amid Rising Youth Abuse
The New Frontier of Prescription Safety: Why Pregabalin is Under the Microscope In a significant move to safeguard public health, the Indian government has officially moved the pain-management drug Pregabalin into the Schedule H1 category. This regulatory shift, finalized in May 2026, marks a turning point in how authorities are tackling the rising tide of … Read more